Morgan Philp

Title: Morgan Philp: Innovator in Drug Detection Technologies

Introduction

Morgan Philp is a notable inventor based in Ultimo, Australia. He has made significant contributions to the field of drug detection, holding 2 patents that showcase his innovative approaches to identifying illicit substances.

Latest Patents

One of his latest patents is the Cathinone test. This method involves detecting the presence of a cathinone moiety in a sample, such as a suspected illicit drug sample. The process includes contacting the sample with a solution that comprises neocuproine, a source of copper(II), and a catalyst, while observing a color change that correlates with the presence of cathinone. This method operates effectively at environmental temperatures, and mechanical elements may be employed to accelerate the color change if desired.

Another significant patent is the NBOMe test. This method detects the presence of an NBOMe in a sample by contacting it with an activated p-quinone, such as 2,3,5,6-tetrachloro-1,4-benzoquinone (TCBQ), and an aldehyde, for example, acetaldehyde. Optionally, a buffer can be included, and the color change observed correlates with the presence of an NBOMe. The ingredients for this test may be provided in a kit that includes a color standard or comparison chart.

Career Highlights

Morgan Philp is affiliated with the University of Technology Sydney, where he continues to advance his research and development in drug detection technologies. His work has garnered attention for its practical applications in forensic science and public safety.

Collaborations

He has collaborated with notable colleagues, including Shanlin Fu and Ronald Shimmon, contributing to a dynamic research environment that fosters innovation.

Conclusion

Morgan Philp's contributions to drug detection through his innovative patents highlight his role as a key figure in this important field. His work not only advances scientific knowledge but also has practical implications for society.